Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Envoy Medical (COCH) Accumulated Depreciation & Amortization (2023 - 2026)

Envoy Medical's Accumulated Depreciation & Amortization history spans 4 years, with the latest figure at $5.2 million for Q1 2026.

  • On a quarterly basis, Accumulated Depreciation & Amortization rose 5.95% to $5.2 million in Q1 2026 year-over-year; TTM through Mar 2026 was $5.2 million, a 5.95% increase, with the full-year FY2025 number at $5.1 million, up 5.78% from a year prior.
  • Accumulated Depreciation & Amortization hit $5.2 million in Q1 2026 for Envoy Medical, up from $5.1 million in the prior quarter.
  • Over the last five years, Accumulated Depreciation & Amortization for COCH hit a ceiling of $5.2 million in Q1 2026 and a floor of $4.7 million in Q4 2023.
  • Historically, Accumulated Depreciation & Amortization has averaged $5.0 million across 4 years, with a median of $5.0 million in 2025.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: grew 3.71% in 2024 and later increased 5.95% in 2026.
  • Tracing COCH's Accumulated Depreciation & Amortization over 4 years: stood at $4.7 million in 2023, then grew by 3.71% to $4.8 million in 2024, then increased by 5.78% to $5.1 million in 2025, then grew by 1.43% to $5.2 million in 2026.
  • Business Quant data shows Accumulated Depreciation & Amortization for COCH at $5.2 million in Q1 2026, $5.1 million in Q4 2025, and $5.1 million in Q3 2025.